Interestingly, however, pancreatic cancer cells are more resistant to gemcitabine than other chemotherapeutic drugs [46], making C/EBPδ an attractive transcription factor in the setting of chemoresistance in PDAC. The gene discussed is CEBPD; the disease is pancreatic neoplasm.